Epoprostenol Injection, Powder, Lyophilized, For Solution
Product Images NDC 62756-060

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Epoprostenol (NDC 62756-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-epoprostenol-carton-1 (Spl Epoprostenol Carton 1)

Spl-epoprostenol-carton-1 (Spl Epoprostenol Carton 1)
Packaging label for Epoprostenol injection 0.5 mg (500,000 ng) per vial. It is a sterile, lyophilized powder for intravenous infusion. The label includes storage instructions, content details, and manufacturer information for Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Spl-epoprostenol-carton-2 (Spl Epoprostenol Carton 2)

Spl-epoprostenol-carton-2 (Spl Epoprostenol Carton 2)
Packaging label for Epoprostenol for Injection 1.5 mg (1,500,000 ng)/vial, a sterile, lyophilized powder for intravenous infusion. The single-dose vial is manufactured by Sun Pharmaceutical Industries, Inc. The label includes dosage form, strength, storage instructions, and barcode information.*
FDA Label Image

Spl-epoprostenol-formula (Spl Epoprostenol Formula)

Spl-epoprostenol-formula (Spl Epoprostenol Formula)
A text panel displaying a formula to calculate the infusion rate in mL/hr for a medication. The formula is: Infusion Rate (mL/hr) equals Dose (ng/kg/min) multiplied by Weight (kg) multiplied by 60 min/hr, divided by Final Concentration (ng/mL).*
FDA Label Image

Spl-epoprostenol-structure (Spl Epoprostenol Structure)

Spl-epoprostenol-structure (Spl Epoprostenol Structure)
Chemical structure of epoprostenol, showing its molecular framework including carboxylate sodium salt, hydroxyl groups, and conjugated double bonds.*
FDA Label Image

Spl-epoprostenol-vial-1 (Spl Epoprostenol Vial 1)

Spl-epoprostenol-vial-1 (Spl Epoprostenol Vial 1)
Label for epoprostenol for Injection 0.5 mg (500,000 ng) per vial, lyophilized powder for intravenous infusion. The label states a 10 mL single-dose vial, sterility, and instructions to discard unused portions. It includes storage conditions and manufacturer information for Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Spl-epoprostenol-vial-2 (Spl Epoprostenol Vial 2)

Spl-epoprostenol-vial-2 (Spl Epoprostenol Vial 2)
Label for Epoprostenol for Injection 1.5 mg (1,500,000 ng) per vial, a lyophilized powder for solution. The vial is single-dose with a 10 mL volume for intravenous infusion only. Labeler is Sun Pharmaceutical Industries, Inc. Storage instructions specify 20° to 25°C with permitted excursions and protection from light. The label includes NDC 62756-060-40 and batch/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.